Murine mastocytoma P815 induces CTL responses against at least four distinct Ags (AB, C, D, and E), Recent studies have shown that the main component of the CTL response against the P815 tumor is targeted against Ags P815AB and P815E, The gene PIA has been well characterized, It encodes the P815AB Ag in the form of a nonameric peptide containing two epitopes, P815A and P815B, which are recognized by different CTLs. Here, we report the identification of the P815E Ag, Using a cDNA library derived from tumor P815, we identified the gene coding for P815E. We also characterized the antigenic peptide that anti-P815E CTLs recognize on the MHC class I molecule H-2K(d), The P815E Ag results from a mutation within an ubiquitously expressed gene encod...
Tumor immunology has come into the limelight since the realization that antitumor cytotoxic T lympho...
Immunization of DBA/2 (H-2d) mice with syngeneic P815 tumor cell transfectants that express HLA clas...
Purpose: For identification of CTL epitopes useful for cancer vaccines, it is crucial to determine w...
We showed previously that mouse mastocytoma P815 expresses several distinct antigens that are recogn...
Mouse mastocytoma P815 expresses several distinct tumor rejection antigens recognized by syngeneic c...
Mouse mastocytoma P815 expresses several distinct tumor rejection antigens recognized by syngeneic c...
A DNA immunization approach was used to induce an immune response against the tumor-specific antigen...
A number of human tumor antigens have been characterized recently using cytolytic T lymphocytes (CTL...
Mouse mastocytoma P815 expresses tumor antigens P815A and P815B encoded by a single gene called P1A ...
Immunogenic tumor cell variant P35 was obtained by mutagen treatment of mouse mastocytoma P815. It e...
In murine mastocytoma P815, gene P1A directs the expression of antigens P815A and B which are the ta...
The cytolytic T lymphocyte (CTL) response of syngeneic mice to antigenic variants obtained by mutage...
There is evidence suggesting CD4+CD25+ regulatory T cells may impede generation of effective immunit...
Cancer immunotherapy continues to make headway as a treatment for advanced stage tumors, revealing a...
We reported previously that the mouse tumor P815 expresses four distinct antigens (A, B, C, D) recog...
Tumor immunology has come into the limelight since the realization that antitumor cytotoxic T lympho...
Immunization of DBA/2 (H-2d) mice with syngeneic P815 tumor cell transfectants that express HLA clas...
Purpose: For identification of CTL epitopes useful for cancer vaccines, it is crucial to determine w...
We showed previously that mouse mastocytoma P815 expresses several distinct antigens that are recogn...
Mouse mastocytoma P815 expresses several distinct tumor rejection antigens recognized by syngeneic c...
Mouse mastocytoma P815 expresses several distinct tumor rejection antigens recognized by syngeneic c...
A DNA immunization approach was used to induce an immune response against the tumor-specific antigen...
A number of human tumor antigens have been characterized recently using cytolytic T lymphocytes (CTL...
Mouse mastocytoma P815 expresses tumor antigens P815A and P815B encoded by a single gene called P1A ...
Immunogenic tumor cell variant P35 was obtained by mutagen treatment of mouse mastocytoma P815. It e...
In murine mastocytoma P815, gene P1A directs the expression of antigens P815A and B which are the ta...
The cytolytic T lymphocyte (CTL) response of syngeneic mice to antigenic variants obtained by mutage...
There is evidence suggesting CD4+CD25+ regulatory T cells may impede generation of effective immunit...
Cancer immunotherapy continues to make headway as a treatment for advanced stage tumors, revealing a...
We reported previously that the mouse tumor P815 expresses four distinct antigens (A, B, C, D) recog...
Tumor immunology has come into the limelight since the realization that antitumor cytotoxic T lympho...
Immunization of DBA/2 (H-2d) mice with syngeneic P815 tumor cell transfectants that express HLA clas...
Purpose: For identification of CTL epitopes useful for cancer vaccines, it is crucial to determine w...